nodes	percent_of_prediction	percent_of_DWPC	metapath
Leucovorin—Methotrexate—testicular cancer	0.439	1	CrCtD
Leucovorin—Folic Acid—Methotrexate—testicular cancer	0.058	0.2	CrCrCtD
Leucovorin—Pralatrexate—Methotrexate—testicular cancer	0.058	0.2	CrCrCtD
Leucovorin—Pemetrexed—Methotrexate—testicular cancer	0.058	0.2	CrCrCtD
Leucovorin—Raltitrexed—Methotrexate—testicular cancer	0.058	0.2	CrCrCtD
Leucovorin—Tetrahydrofolic acid—Methotrexate—testicular cancer	0.058	0.2	CrCrCtD
Leucovorin—TYMS—Methotrexate—testicular cancer	0.0375	0.165	CbGbCtD
Leucovorin—ABCC3—Cisplatin—testicular cancer	0.0299	0.132	CbGbCtD
Leucovorin—ABCC3—Etoposide—testicular cancer	0.0294	0.13	CbGbCtD
Leucovorin—ABCC3—Doxorubicin—testicular cancer	0.0201	0.0885	CbGbCtD
Leucovorin—ABCC3—Methotrexate—testicular cancer	0.0194	0.0857	CbGbCtD
Leucovorin—ABCC2—Carboplatin—testicular cancer	0.0159	0.0702	CbGbCtD
Leucovorin—ABCC4—Methotrexate—testicular cancer	0.0148	0.0655	CbGbCtD
Leucovorin—ABCC2—Vinblastine—testicular cancer	0.0148	0.0654	CbGbCtD
Leucovorin—ABCC2—Cisplatin—testicular cancer	0.0136	0.06	CbGbCtD
Leucovorin—ABCC2—Etoposide—testicular cancer	0.0134	0.0589	CbGbCtD
Leucovorin—ABCC2—Doxorubicin—testicular cancer	0.00911	0.0402	CbGbCtD
Leucovorin—ABCC2—Methotrexate—testicular cancer	0.00883	0.0389	CbGbCtD
Leucovorin—TYMS—Vinorelbine—Vinblastine—testicular cancer	0.000398	0.35	CbGdCrCtD
Leucovorin—TYMS—Podofilox—Etoposide—testicular cancer	0.000398	0.35	CbGdCrCtD
Leucovorin—TYMS—Vincristine—Vinblastine—testicular cancer	0.000341	0.3	CbGdCrCtD
Leucovorin—Pruritus—Chlorambucil—testicular cancer	0.000108	0.0025	CcSEcCtD
Leucovorin—Thrombocytopenia—Dactinomycin—testicular cancer	0.000108	0.0025	CcSEcCtD
Leucovorin—Convulsion—Ifosfamide—testicular cancer	0.000108	0.00248	CcSEcCtD
Leucovorin—Erythema—Cisplatin—testicular cancer	0.000107	0.00247	CcSEcCtD
Leucovorin—Dyspnoea—Bleomycin—testicular cancer	0.000106	0.00244	CcSEcCtD
Leucovorin—Renal failure acute—Methotrexate—testicular cancer	0.000106	0.00244	CcSEcCtD
Leucovorin—Anorexia—Dactinomycin—testicular cancer	0.000105	0.00243	CcSEcCtD
Leucovorin—Diarrhoea—Chlorambucil—testicular cancer	0.000105	0.00242	CcSEcCtD
Leucovorin—Discomfort—Ifosfamide—testicular cancer	0.000104	0.00241	CcSEcCtD
Leucovorin—Hypersensitivity—Vinblastine—testicular cancer	0.000103	0.00239	CcSEcCtD
Leucovorin—Decreased appetite—Bleomycin—testicular cancer	0.000103	0.00238	CcSEcCtD
Leucovorin—Confusional state—Ifosfamide—testicular cancer	0.000102	0.00236	CcSEcCtD
Leucovorin—Anaphylactic shock—Ifosfamide—testicular cancer	0.000101	0.00234	CcSEcCtD
Leucovorin—Chills—Etoposide—testicular cancer	0.000101	0.00233	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Methotrexate—testicular cancer	0.000101	0.00232	CcSEcCtD
Leucovorin—Asthenia—Vinblastine—testicular cancer	0.000101	0.00232	CcSEcCtD
Leucovorin—Infection—Ifosfamide—testicular cancer	0.000101	0.00232	CcSEcCtD
Leucovorin—Alopecia—Etoposide—testicular cancer	9.96e-05	0.0023	CcSEcCtD
Leucovorin—Lethargy—Methotrexate—testicular cancer	9.95e-05	0.0023	CcSEcCtD
Leucovorin—Ill-defined disorder—Cisplatin—testicular cancer	9.93e-05	0.00229	CcSEcCtD
Leucovorin—Thrombocytopenia—Ifosfamide—testicular cancer	9.92e-05	0.00229	CcSEcCtD
Leucovorin—Renal failure acute—Epirubicin—testicular cancer	9.89e-05	0.00228	CcSEcCtD
Leucovorin—Skin disorder—Ifosfamide—testicular cancer	9.84e-05	0.00227	CcSEcCtD
Leucovorin—Feeling abnormal—Bleomycin—testicular cancer	9.77e-05	0.00225	CcSEcCtD
Leucovorin—Vomiting—Chlorambucil—testicular cancer	9.74e-05	0.00225	CcSEcCtD
Leucovorin—Anorexia—Ifosfamide—testicular cancer	9.66e-05	0.00223	CcSEcCtD
Leucovorin—Malaise—Cisplatin—testicular cancer	9.65e-05	0.00223	CcSEcCtD
Leucovorin—Decreased appetite—Dactinomycin—testicular cancer	9.61e-05	0.00222	CcSEcCtD
Leucovorin—Diarrhoea—Vinblastine—testicular cancer	9.61e-05	0.00222	CcSEcCtD
Leucovorin—Dysgeusia—Etoposide—testicular cancer	9.6e-05	0.00222	CcSEcCtD
Leucovorin—Renal impairment—Epirubicin—testicular cancer	9.59e-05	0.00221	CcSEcCtD
Leucovorin—Leukopenia—Cisplatin—testicular cancer	9.58e-05	0.00221	CcSEcCtD
Leucovorin—Fatigue—Dactinomycin—testicular cancer	9.54e-05	0.0022	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Epirubicin—testicular cancer	9.43e-05	0.00218	CcSEcCtD
Leucovorin—Urticaria—Bleomycin—testicular cancer	9.42e-05	0.00217	CcSEcCtD
Leucovorin—Body temperature increased—Bleomycin—testicular cancer	9.37e-05	0.00216	CcSEcCtD
Leucovorin—Lethargy—Epirubicin—testicular cancer	9.32e-05	0.00215	CcSEcCtD
Leucovorin—Dizziness—Vinblastine—testicular cancer	9.28e-05	0.00214	CcSEcCtD
Leucovorin—Convulsion—Cisplatin—testicular cancer	9.28e-05	0.00214	CcSEcCtD
Leucovorin—Renal failure acute—Doxorubicin—testicular cancer	9.15e-05	0.00211	CcSEcCtD
Leucovorin—Feeling abnormal—Dactinomycin—testicular cancer	9.11e-05	0.0021	CcSEcCtD
Leucovorin—Nausea—Chlorambucil—testicular cancer	9.1e-05	0.0021	CcSEcCtD
Leucovorin—Ill-defined disorder—Etoposide—testicular cancer	9.1e-05	0.0021	CcSEcCtD
Leucovorin—Gastrointestinal pain—Dactinomycin—testicular cancer	9.04e-05	0.00209	CcSEcCtD
Leucovorin—Dyspnoea—Ifosfamide—testicular cancer	9.04e-05	0.00208	CcSEcCtD
Leucovorin—Discomfort—Cisplatin—testicular cancer	9.01e-05	0.00208	CcSEcCtD
Leucovorin—Vomiting—Vinblastine—testicular cancer	8.93e-05	0.00206	CcSEcCtD
Leucovorin—Renal impairment—Doxorubicin—testicular cancer	8.88e-05	0.00205	CcSEcCtD
Leucovorin—Malaise—Etoposide—testicular cancer	8.84e-05	0.00204	CcSEcCtD
Leucovorin—Decreased appetite—Ifosfamide—testicular cancer	8.81e-05	0.00203	CcSEcCtD
Leucovorin—Leukopenia—Etoposide—testicular cancer	8.78e-05	0.00202	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Ifosfamide—testicular cancer	8.75e-05	0.00202	CcSEcCtD
Leucovorin—Abdominal pain—Dactinomycin—testicular cancer	8.74e-05	0.00202	CcSEcCtD
Leucovorin—Body temperature increased—Dactinomycin—testicular cancer	8.74e-05	0.00202	CcSEcCtD
Leucovorin—Fatigue—Ifosfamide—testicular cancer	8.74e-05	0.00202	CcSEcCtD
Leucovorin—Anaphylactic shock—Cisplatin—testicular cancer	8.74e-05	0.00202	CcSEcCtD
Leucovorin—Hypersensitivity—Bleomycin—testicular cancer	8.74e-05	0.00202	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Doxorubicin—testicular cancer	8.73e-05	0.00201	CcSEcCtD
Leucovorin—Infection—Cisplatin—testicular cancer	8.68e-05	0.002	CcSEcCtD
Leucovorin—Constipation—Ifosfamide—testicular cancer	8.67e-05	0.002	CcSEcCtD
Leucovorin—Loss of consciousness—Etoposide—testicular cancer	8.62e-05	0.00199	CcSEcCtD
Leucovorin—Lethargy—Doxorubicin—testicular cancer	8.62e-05	0.00199	CcSEcCtD
Leucovorin—Thrombocytopenia—Cisplatin—testicular cancer	8.55e-05	0.00197	CcSEcCtD
Leucovorin—Blood creatinine increased—Epirubicin—testicular cancer	8.55e-05	0.00197	CcSEcCtD
Leucovorin—Asthenia—Bleomycin—testicular cancer	8.51e-05	0.00196	CcSEcCtD
Leucovorin—Convulsion—Etoposide—testicular cancer	8.5e-05	0.00196	CcSEcCtD
Leucovorin—Skin disorder—Cisplatin—testicular cancer	8.49e-05	0.00196	CcSEcCtD
Leucovorin—Pruritus—Bleomycin—testicular cancer	8.39e-05	0.00194	CcSEcCtD
Leucovorin—Feeling abnormal—Ifosfamide—testicular cancer	8.35e-05	0.00193	CcSEcCtD
Leucovorin—Nausea—Vinblastine—testicular cancer	8.34e-05	0.00192	CcSEcCtD
Leucovorin—Abdominal pain upper—Epirubicin—testicular cancer	8.34e-05	0.00192	CcSEcCtD
Leucovorin—Anorexia—Cisplatin—testicular cancer	8.33e-05	0.00192	CcSEcCtD
Leucovorin—Gastrointestinal pain—Ifosfamide—testicular cancer	8.29e-05	0.00191	CcSEcCtD
Leucovorin—Discomfort—Etoposide—testicular cancer	8.25e-05	0.0019	CcSEcCtD
Leucovorin—Hypersensitivity—Dactinomycin—testicular cancer	8.15e-05	0.00188	CcSEcCtD
Leucovorin—Confusional state—Etoposide—testicular cancer	8.07e-05	0.00186	CcSEcCtD
Leucovorin—Urticaria—Ifosfamide—testicular cancer	8.05e-05	0.00186	CcSEcCtD
Leucovorin—Body temperature increased—Ifosfamide—testicular cancer	8.01e-05	0.00185	CcSEcCtD
Leucovorin—Abdominal pain—Ifosfamide—testicular cancer	8.01e-05	0.00185	CcSEcCtD
Leucovorin—Anaphylactic shock—Etoposide—testicular cancer	8e-05	0.00185	CcSEcCtD
Leucovorin—Infection—Etoposide—testicular cancer	7.95e-05	0.00183	CcSEcCtD
Leucovorin—Asthenia—Dactinomycin—testicular cancer	7.94e-05	0.00183	CcSEcCtD
Leucovorin—Blood creatinine increased—Doxorubicin—testicular cancer	7.91e-05	0.00183	CcSEcCtD
Leucovorin—Thrombocytopenia—Etoposide—testicular cancer	7.84e-05	0.00181	CcSEcCtD
Leucovorin—Dyspnoea—Cisplatin—testicular cancer	7.79e-05	0.0018	CcSEcCtD
Leucovorin—Skin disorder—Etoposide—testicular cancer	7.77e-05	0.00179	CcSEcCtD
Leucovorin—Abdominal pain upper—Doxorubicin—testicular cancer	7.71e-05	0.00178	CcSEcCtD
Leucovorin—Anorexia—Etoposide—testicular cancer	7.63e-05	0.00176	CcSEcCtD
Leucovorin—Decreased appetite—Cisplatin—testicular cancer	7.6e-05	0.00175	CcSEcCtD
Leucovorin—Diarrhoea—Dactinomycin—testicular cancer	7.57e-05	0.00175	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Cisplatin—testicular cancer	7.54e-05	0.00174	CcSEcCtD
Leucovorin—Vomiting—Bleomycin—testicular cancer	7.54e-05	0.00174	CcSEcCtD
Leucovorin—Rash—Bleomycin—testicular cancer	7.48e-05	0.00172	CcSEcCtD
Leucovorin—Dermatitis—Bleomycin—testicular cancer	7.47e-05	0.00172	CcSEcCtD
Leucovorin—Hypersensitivity—Ifosfamide—testicular cancer	7.47e-05	0.00172	CcSEcCtD
Leucovorin—Stomatitis—Methotrexate—testicular cancer	7.33e-05	0.00169	CcSEcCtD
Leucovorin—Asthenia—Ifosfamide—testicular cancer	7.27e-05	0.00168	CcSEcCtD
Leucovorin—Feeling abnormal—Cisplatin—testicular cancer	7.2e-05	0.00166	CcSEcCtD
Leucovorin—Pruritus—Ifosfamide—testicular cancer	7.17e-05	0.00165	CcSEcCtD
Leucovorin—Dyspnoea—Etoposide—testicular cancer	7.14e-05	0.00165	CcSEcCtD
Leucovorin—Nausea—Bleomycin—testicular cancer	7.04e-05	0.00162	CcSEcCtD
Leucovorin—Vomiting—Dactinomycin—testicular cancer	7.03e-05	0.00162	CcSEcCtD
Leucovorin—Rash—Dactinomycin—testicular cancer	6.97e-05	0.00161	CcSEcCtD
Leucovorin—Decreased appetite—Etoposide—testicular cancer	6.96e-05	0.0016	CcSEcCtD
Leucovorin—Diarrhoea—Ifosfamide—testicular cancer	6.93e-05	0.0016	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Etoposide—testicular cancer	6.91e-05	0.00159	CcSEcCtD
Leucovorin—Body temperature increased—Cisplatin—testicular cancer	6.91e-05	0.00159	CcSEcCtD
Leucovorin—Fatigue—Etoposide—testicular cancer	6.9e-05	0.00159	CcSEcCtD
Leucovorin—Neuropathy peripheral—Epirubicin—testicular cancer	6.9e-05	0.00159	CcSEcCtD
Leucovorin—Stomatitis—Epirubicin—testicular cancer	6.86e-05	0.00158	CcSEcCtD
Leucovorin—Constipation—Etoposide—testicular cancer	6.85e-05	0.00158	CcSEcCtD
Leucovorin—Dizziness—Ifosfamide—testicular cancer	6.7e-05	0.00155	CcSEcCtD
Leucovorin—Feeling abnormal—Etoposide—testicular cancer	6.6e-05	0.00152	CcSEcCtD
Leucovorin—Nausea—Dactinomycin—testicular cancer	6.57e-05	0.00152	CcSEcCtD
Leucovorin—Gastrointestinal pain—Etoposide—testicular cancer	6.55e-05	0.00151	CcSEcCtD
Leucovorin—Vomiting—Ifosfamide—testicular cancer	6.44e-05	0.00149	CcSEcCtD
Leucovorin—Hypersensitivity—Cisplatin—testicular cancer	6.44e-05	0.00148	CcSEcCtD
Leucovorin—Rash—Ifosfamide—testicular cancer	6.39e-05	0.00147	CcSEcCtD
Leucovorin—Dermatitis—Ifosfamide—testicular cancer	6.38e-05	0.00147	CcSEcCtD
Leucovorin—Neuropathy peripheral—Doxorubicin—testicular cancer	6.38e-05	0.00147	CcSEcCtD
Leucovorin—Urticaria—Etoposide—testicular cancer	6.36e-05	0.00147	CcSEcCtD
Leucovorin—Stomatitis—Doxorubicin—testicular cancer	6.35e-05	0.00146	CcSEcCtD
Leucovorin—Abdominal pain—Etoposide—testicular cancer	6.33e-05	0.00146	CcSEcCtD
Leucovorin—Body temperature increased—Etoposide—testicular cancer	6.33e-05	0.00146	CcSEcCtD
Leucovorin—Asthenia—Cisplatin—testicular cancer	6.27e-05	0.00145	CcSEcCtD
Leucovorin—Chills—Methotrexate—testicular cancer	6.06e-05	0.0014	CcSEcCtD
Leucovorin—Nausea—Ifosfamide—testicular cancer	6.02e-05	0.00139	CcSEcCtD
Leucovorin—Diarrhoea—Cisplatin—testicular cancer	5.98e-05	0.00138	CcSEcCtD
Leucovorin—Alopecia—Methotrexate—testicular cancer	5.96e-05	0.00138	CcSEcCtD
Leucovorin—Hypersensitivity—Etoposide—testicular cancer	5.9e-05	0.00136	CcSEcCtD
Leucovorin—Erythema—Methotrexate—testicular cancer	5.87e-05	0.00135	CcSEcCtD
Leucovorin—Dysgeusia—Methotrexate—testicular cancer	5.75e-05	0.00133	CcSEcCtD
Leucovorin—Asthenia—Etoposide—testicular cancer	5.74e-05	0.00132	CcSEcCtD
Leucovorin—Chills—Epirubicin—testicular cancer	5.67e-05	0.00131	CcSEcCtD
Leucovorin—Pruritus—Etoposide—testicular cancer	5.66e-05	0.00131	CcSEcCtD
Leucovorin—Alopecia—Epirubicin—testicular cancer	5.58e-05	0.00129	CcSEcCtD
Leucovorin—Vomiting—Cisplatin—testicular cancer	5.56e-05	0.00128	CcSEcCtD
Leucovorin—Rash—Cisplatin—testicular cancer	5.51e-05	0.00127	CcSEcCtD
Leucovorin—Dermatitis—Cisplatin—testicular cancer	5.5e-05	0.00127	CcSEcCtD
Leucovorin—Erythema—Epirubicin—testicular cancer	5.5e-05	0.00127	CcSEcCtD
Leucovorin—Diarrhoea—Etoposide—testicular cancer	5.48e-05	0.00126	CcSEcCtD
Leucovorin—Ill-defined disorder—Methotrexate—testicular cancer	5.45e-05	0.00126	CcSEcCtD
Leucovorin—Dysgeusia—Epirubicin—testicular cancer	5.38e-05	0.00124	CcSEcCtD
Leucovorin—Malaise—Methotrexate—testicular cancer	5.3e-05	0.00122	CcSEcCtD
Leucovorin—Dizziness—Etoposide—testicular cancer	5.29e-05	0.00122	CcSEcCtD
Leucovorin—Leukopenia—Methotrexate—testicular cancer	5.26e-05	0.00121	CcSEcCtD
Leucovorin—Chills—Doxorubicin—testicular cancer	5.24e-05	0.00121	CcSEcCtD
Leucovorin—Nausea—Cisplatin—testicular cancer	5.19e-05	0.0012	CcSEcCtD
Leucovorin—Alopecia—Doxorubicin—testicular cancer	5.16e-05	0.00119	CcSEcCtD
Leucovorin—Ill-defined disorder—Epirubicin—testicular cancer	5.1e-05	0.00118	CcSEcCtD
Leucovorin—Convulsion—Methotrexate—testicular cancer	5.09e-05	0.00117	CcSEcCtD
Leucovorin—Vomiting—Etoposide—testicular cancer	5.09e-05	0.00117	CcSEcCtD
Leucovorin—Erythema—Doxorubicin—testicular cancer	5.09e-05	0.00117	CcSEcCtD
Leucovorin—Rash—Etoposide—testicular cancer	5.05e-05	0.00116	CcSEcCtD
Leucovorin—Dermatitis—Etoposide—testicular cancer	5.04e-05	0.00116	CcSEcCtD
Leucovorin—Dysgeusia—Doxorubicin—testicular cancer	4.98e-05	0.00115	CcSEcCtD
Leucovorin—Malaise—Epirubicin—testicular cancer	4.96e-05	0.00114	CcSEcCtD
Leucovorin—Discomfort—Methotrexate—testicular cancer	4.94e-05	0.00114	CcSEcCtD
Leucovorin—Syncope—Epirubicin—testicular cancer	4.93e-05	0.00114	CcSEcCtD
Leucovorin—Leukopenia—Epirubicin—testicular cancer	4.92e-05	0.00114	CcSEcCtD
Leucovorin—Confusional state—Methotrexate—testicular cancer	4.83e-05	0.00112	CcSEcCtD
Leucovorin—Loss of consciousness—Epirubicin—testicular cancer	4.83e-05	0.00111	CcSEcCtD
Leucovorin—Anaphylactic shock—Methotrexate—testicular cancer	4.79e-05	0.00111	CcSEcCtD
Leucovorin—Convulsion—Epirubicin—testicular cancer	4.76e-05	0.0011	CcSEcCtD
Leucovorin—Infection—Methotrexate—testicular cancer	4.76e-05	0.0011	CcSEcCtD
Leucovorin—Nausea—Etoposide—testicular cancer	4.75e-05	0.0011	CcSEcCtD
Leucovorin—Ill-defined disorder—Doxorubicin—testicular cancer	4.72e-05	0.00109	CcSEcCtD
Leucovorin—Thrombocytopenia—Methotrexate—testicular cancer	4.69e-05	0.00108	CcSEcCtD
Leucovorin—Skin disorder—Methotrexate—testicular cancer	4.66e-05	0.00107	CcSEcCtD
Leucovorin—Discomfort—Epirubicin—testicular cancer	4.62e-05	0.00107	CcSEcCtD
Leucovorin—Malaise—Doxorubicin—testicular cancer	4.59e-05	0.00106	CcSEcCtD
Leucovorin—Anorexia—Methotrexate—testicular cancer	4.57e-05	0.00105	CcSEcCtD
Leucovorin—Syncope—Doxorubicin—testicular cancer	4.56e-05	0.00105	CcSEcCtD
Leucovorin—Leukopenia—Doxorubicin—testicular cancer	4.55e-05	0.00105	CcSEcCtD
Leucovorin—Confusional state—Epirubicin—testicular cancer	4.52e-05	0.00104	CcSEcCtD
Leucovorin—Anaphylactic shock—Epirubicin—testicular cancer	4.49e-05	0.00103	CcSEcCtD
Leucovorin—Loss of consciousness—Doxorubicin—testicular cancer	4.47e-05	0.00103	CcSEcCtD
Leucovorin—Infection—Epirubicin—testicular cancer	4.46e-05	0.00103	CcSEcCtD
Leucovorin—Shock—Epirubicin—testicular cancer	4.41e-05	0.00102	CcSEcCtD
Leucovorin—Convulsion—Doxorubicin—testicular cancer	4.41e-05	0.00102	CcSEcCtD
Leucovorin—Thrombocytopenia—Epirubicin—testicular cancer	4.39e-05	0.00101	CcSEcCtD
Leucovorin—Skin disorder—Epirubicin—testicular cancer	4.36e-05	0.00101	CcSEcCtD
Leucovorin—Discomfort—Doxorubicin—testicular cancer	4.28e-05	0.000987	CcSEcCtD
Leucovorin—Anorexia—Epirubicin—testicular cancer	4.28e-05	0.000986	CcSEcCtD
Leucovorin—Dyspnoea—Methotrexate—testicular cancer	4.27e-05	0.000986	CcSEcCtD
Leucovorin—Dyspepsia—Methotrexate—testicular cancer	4.22e-05	0.000973	CcSEcCtD
Leucovorin—Confusional state—Doxorubicin—testicular cancer	4.19e-05	0.000965	CcSEcCtD
Leucovorin—Decreased appetite—Methotrexate—testicular cancer	4.17e-05	0.000961	CcSEcCtD
Leucovorin—Anaphylactic shock—Doxorubicin—testicular cancer	4.15e-05	0.000958	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Methotrexate—testicular cancer	4.14e-05	0.000955	CcSEcCtD
Leucovorin—Fatigue—Methotrexate—testicular cancer	4.13e-05	0.000953	CcSEcCtD
Leucovorin—Infection—Doxorubicin—testicular cancer	4.12e-05	0.000951	CcSEcCtD
Leucovorin—Shock—Doxorubicin—testicular cancer	4.08e-05	0.000942	CcSEcCtD
Leucovorin—Thrombocytopenia—Doxorubicin—testicular cancer	4.06e-05	0.000938	CcSEcCtD
Leucovorin—Skin disorder—Doxorubicin—testicular cancer	4.03e-05	0.00093	CcSEcCtD
Leucovorin—Dyspnoea—Epirubicin—testicular cancer	4e-05	0.000923	CcSEcCtD
Leucovorin—Anorexia—Doxorubicin—testicular cancer	3.96e-05	0.000913	CcSEcCtD
Leucovorin—Feeling abnormal—Methotrexate—testicular cancer	3.95e-05	0.000911	CcSEcCtD
Leucovorin—Dyspepsia—Epirubicin—testicular cancer	3.95e-05	0.000911	CcSEcCtD
Leucovorin—Gastrointestinal pain—Methotrexate—testicular cancer	3.92e-05	0.000904	CcSEcCtD
Leucovorin—Decreased appetite—Epirubicin—testicular cancer	3.9e-05	0.0009	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Epirubicin—testicular cancer	3.87e-05	0.000893	CcSEcCtD
Leucovorin—Fatigue—Epirubicin—testicular cancer	3.87e-05	0.000892	CcSEcCtD
Leucovorin—Constipation—Epirubicin—testicular cancer	3.84e-05	0.000885	CcSEcCtD
Leucovorin—Urticaria—Methotrexate—testicular cancer	3.81e-05	0.000878	CcSEcCtD
Leucovorin—Body temperature increased—Methotrexate—testicular cancer	3.79e-05	0.000874	CcSEcCtD
Leucovorin—Abdominal pain—Methotrexate—testicular cancer	3.79e-05	0.000874	CcSEcCtD
Leucovorin—Dyspnoea—Doxorubicin—testicular cancer	3.7e-05	0.000854	CcSEcCtD
Leucovorin—Feeling abnormal—Epirubicin—testicular cancer	3.7e-05	0.000853	CcSEcCtD
Leucovorin—Gastrointestinal pain—Epirubicin—testicular cancer	3.67e-05	0.000846	CcSEcCtD
Leucovorin—Dyspepsia—Doxorubicin—testicular cancer	3.65e-05	0.000843	CcSEcCtD
Leucovorin—Decreased appetite—Doxorubicin—testicular cancer	3.61e-05	0.000832	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Doxorubicin—testicular cancer	3.58e-05	0.000827	CcSEcCtD
Leucovorin—Fatigue—Doxorubicin—testicular cancer	3.58e-05	0.000826	CcSEcCtD
Leucovorin—Urticaria—Epirubicin—testicular cancer	3.56e-05	0.000822	CcSEcCtD
Leucovorin—Constipation—Doxorubicin—testicular cancer	3.55e-05	0.000819	CcSEcCtD
Leucovorin—Body temperature increased—Epirubicin—testicular cancer	3.55e-05	0.000818	CcSEcCtD
Leucovorin—Abdominal pain—Epirubicin—testicular cancer	3.55e-05	0.000818	CcSEcCtD
Leucovorin—Hypersensitivity—Methotrexate—testicular cancer	3.53e-05	0.000815	CcSEcCtD
Leucovorin—Asthenia—Methotrexate—testicular cancer	3.44e-05	0.000793	CcSEcCtD
Leucovorin—Feeling abnormal—Doxorubicin—testicular cancer	3.42e-05	0.000789	CcSEcCtD
Leucovorin—Gastrointestinal pain—Doxorubicin—testicular cancer	3.39e-05	0.000783	CcSEcCtD
Leucovorin—Pruritus—Methotrexate—testicular cancer	3.39e-05	0.000782	CcSEcCtD
Leucovorin—Hypersensitivity—Epirubicin—testicular cancer	3.31e-05	0.000762	CcSEcCtD
Leucovorin—Urticaria—Doxorubicin—testicular cancer	3.3e-05	0.000761	CcSEcCtD
Leucovorin—Abdominal pain—Doxorubicin—testicular cancer	3.28e-05	0.000757	CcSEcCtD
Leucovorin—Body temperature increased—Doxorubicin—testicular cancer	3.28e-05	0.000757	CcSEcCtD
Leucovorin—Diarrhoea—Methotrexate—testicular cancer	3.28e-05	0.000757	CcSEcCtD
Leucovorin—Asthenia—Epirubicin—testicular cancer	3.22e-05	0.000742	CcSEcCtD
Leucovorin—Pruritus—Epirubicin—testicular cancer	3.17e-05	0.000732	CcSEcCtD
Leucovorin—Dizziness—Methotrexate—testicular cancer	3.17e-05	0.000731	CcSEcCtD
Leucovorin—Diarrhoea—Epirubicin—testicular cancer	3.07e-05	0.000708	CcSEcCtD
Leucovorin—Hypersensitivity—Doxorubicin—testicular cancer	3.06e-05	0.000705	CcSEcCtD
Leucovorin—Vomiting—Methotrexate—testicular cancer	3.05e-05	0.000703	CcSEcCtD
Leucovorin—Rash—Methotrexate—testicular cancer	3.02e-05	0.000697	CcSEcCtD
Leucovorin—Dermatitis—Methotrexate—testicular cancer	3.02e-05	0.000697	CcSEcCtD
Leucovorin—Asthenia—Doxorubicin—testicular cancer	2.98e-05	0.000687	CcSEcCtD
Leucovorin—Dizziness—Epirubicin—testicular cancer	2.97e-05	0.000684	CcSEcCtD
Leucovorin—Pruritus—Doxorubicin—testicular cancer	2.94e-05	0.000677	CcSEcCtD
Leucovorin—Vomiting—Epirubicin—testicular cancer	2.85e-05	0.000658	CcSEcCtD
Leucovorin—Nausea—Methotrexate—testicular cancer	2.85e-05	0.000657	CcSEcCtD
Leucovorin—Diarrhoea—Doxorubicin—testicular cancer	2.84e-05	0.000655	CcSEcCtD
Leucovorin—Rash—Epirubicin—testicular cancer	2.83e-05	0.000653	CcSEcCtD
Leucovorin—Dermatitis—Epirubicin—testicular cancer	2.83e-05	0.000652	CcSEcCtD
Leucovorin—Dizziness—Doxorubicin—testicular cancer	2.75e-05	0.000633	CcSEcCtD
Leucovorin—Nausea—Epirubicin—testicular cancer	2.67e-05	0.000615	CcSEcCtD
Leucovorin—Vomiting—Doxorubicin—testicular cancer	2.64e-05	0.000609	CcSEcCtD
Leucovorin—Rash—Doxorubicin—testicular cancer	2.62e-05	0.000604	CcSEcCtD
Leucovorin—Dermatitis—Doxorubicin—testicular cancer	2.62e-05	0.000603	CcSEcCtD
Leucovorin—Nausea—Doxorubicin—testicular cancer	2.47e-05	0.000569	CcSEcCtD
